Singapore markets close in 4 hours 1 minute

Jinxin Fertility Group Limited (1951.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.790+0.130 (+4.89%)
As of 11:59AM HKT. Market open.

Jinxin Fertility Group Limited

No. 301, North Jingsha Road
Jinjiang District
Chengdu
China
86 28 6769 5992
https://www.jxr-fertility.com

Sector(s)Healthcare
IndustryMedical Care Facilities
Full-time employees3,273

Key executives

NameTitlePayExercisedYear born
Mr. Yong ZhongExecutive Chairman of the Board4.04MN/A1972
Mr. Yang DongCo-CEO & Executive Director2.91MN/A1986
Ms. Rong LyuCO-CEO & Executive Director3.57MN/A1981
Dr. John G. Wilcox FACOG, M.D.Executive DirectorN/AN/A1964
Dr. Lihong GengChief Medical Quality Control Officer & Executive Director1.63MN/A1969
Ms. Hanmei HuangChief Financial OfficerN/AN/A1981
Ms. Hongkun LiuVP & Head of Strategic InvestmentN/AN/A1989
Dr. Ling ChiChief Scientific OfficerN/AN/A1955
Ms. Pu ShiVP and Head of Human Resources & AdministrationN/AN/A1975
Mr. Yong ZengSenior Vice PresidentN/AN/A1966
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; obstetrics, gynecology, urology, internal medicine, and pediatrics medical services; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, postpartum and rehabilitation care, property investment, and real estate development and operation activities. Additionally, the company is involved in the sale of medicines, consumables, and equipment; and research and development of IVF related projects, including scientific research and related commercialization. Jinxin Fertility Group Limited was founded in 1951 and is headquartered in Chengdu, China.

Corporate governance

Jinxin Fertility Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.